Violette Clinical Trial (Targeted Microwave Ablation)

About Koelis

Koelis is a private, commercial-stage medical device company headquartered in Grenoble, France, focused on the oncology sector, specifically prostate cancer. The company's flagship product is the Koelis Trinity® system, an integrated mobile platform that fuses MRI and 3D ultrasound imaging to enable highly accurate, targeted prostate biopsies and focal therapies. Beyond its commercial technology, Koelis is actively conducting clinical research, such as the Violette trial, to validate focal microwave ablation as a treatment alternative, positioning itself as a comprehensive solution provider in the growing market for precision urology. The company generates revenue from the sale of its platform and is expanding its clinical evidence base to support broader adoption.

Therapeutic Areas